Onderneming Summit Therapeutics plc London S.E.
Aandelen
GB00BN40HZ01
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 11-11-20 |
Robert Duggan
CEO | Chief Executive Officer | 79 | 01-12-19 |
Director of Finance/CFO | 46 | 01-12-19 | |
Howard West
CTO | Chief Tech/Sci/R&D Officer | - | 19-10-23 |
Allen Yang
CTO | Chief Tech/Sci/R&D Officer | - | 16-10-23 |
Will Black
CTO | Chief Tech/Sci/R&D Officer | - | - |
Dave Gancarz
PRN | Corporate Officer/Principal | - | - |
Campbell Hair
HRO | Human Resources Officer | - | 01-10-20 |
Urte Gayko
PRN | Corporate Officer/Principal | 53 | 03-11-21 |
Shelley Spray
PRN | Corporate Officer/Principal | 59 | 01-06-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Duggan
CEO | Chief Executive Officer | 79 | 01-12-19 |
Robert Booth
BRD | Director/Board Member | 70 | 28-09-22 |
Director of Finance/CFO | 46 | 01-12-19 | |
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 11-11-20 |
Kenneth Clark
BRD | Director/Board Member | 65 | 07-10-21 |
Director/Board Member | 63 | 15-11-22 | |
Urte Gayko
PRN | Corporate Officer/Principal | 53 | 03-11-21 |
Michelle Xia
BRD | Director/Board Member | 58 | 16-01-23 |
Ujwala Mahatme
BRD | Director/Board Member | 59 | 13-07-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 701 979 596 | 83 228 173 ( 11,86 %) | 0 | 11,86 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,79% | 116 mld. | |
+11,65% | 106 mld. | |
-6,20% | 23,89 mld. | |
-3,41% | 21,58 mld. | |
-11,04% | 18,96 mld. | |
-13,41% | 16,33 mld. | |
-40,50% | 16,96 mld. | |
+6,64% | 14,14 mld. | |
+31,84% | 12,02 mld. |